Semaglutide

• Non-stimulating
• Safe and effective for long-term use
• Clients are monitored monthly for safety and efficacy
• Reduced appetite
• Noticeable weight loss can occur within the first 1-2 months

How It Works

Belonging to the class of drugs called GLP-1 receptor agonists, Semaglutide works by mimicking the function of a hormone in the body known as glucagon-like peptide-1 (GLP-1). This helps regulate blood sugar levels by stimulating insulin release and reducing the production of glucagon, a hormone that raises blood sugar.

Important Safety Information

Mechanism of Action: Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist that belongs to a class of drugs called incretin mimetics. Incretins are a type of hormone that stimulate a decrease in blood glucose levels, such as GLP-1 that binds to and activates the GLP-1 receptor. GLP-1 works to regulate ones appetite and caloric intake, and the GLP-1 receptor is present in several areas of your body, including areas in your brain responsible for appetite regulation. Semaglutide, as an agonist, binds to the GLP-1 receptor and works to lower blood glucose by stimulating insulin secretion and to inhibit glucagon release.

Adverse Reactions: Semaglutide is associated with GI adverse reactions, including nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, abdominal distention, eructation, flatulence, gastroenteritis, and gastroesophageal reflux disease. It has also been associated with causing headache, fatigue, dizziness, and hypoglycemia in patients with type 2 diabetes. Please discuss with your physician the contraindications and other warning and precautions before starting Semaglutide.

What Benefits Have Been Reported?

• Weight loss
• Lower A1c
• Lower blood sugar
• Increased insulin secretion
• Reduced appetite
• Lower blood pressure